862283-69-0

Basic information

• Product Name: Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate
• Synonyms: Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate
• CAS NO: 862283-69-0
• Molecular Formula: C₁₉H₂₀ClNO₂
• Molecular Weight: 329.8206
• Mol File: 862283-69-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate(862283-69-0)
• EPA Substance Registry System: Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate(862283-69-0)

Safety Data

• Hazardous Substances Data: 862283-69-0(Hazardous Substances Data)

Usage

Description

Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate is a pyrrolidine carboxylate derivative with a trans configuration, featuring a methyl, benzyl, and chlorophenyl group in its structure. This chemical compound is known for its unique chemical properties and potential applications in the synthesis of pharmaceuticals and other organic compounds.

Uses

Used in Pharmaceutical Industry:
Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate is used as an intermediate in the synthesis of various pharmaceuticals for its unique chemical properties and potential applications in chemical and pharmaceutical processes.
Used in Organic Compounds Synthesis:
Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate is also used as an intermediate in the synthesis of other organic compounds, contributing to the development of new chemical entities and materials.
It is important to handle Trans-Methyl 1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylate with caution due to potential health and safety risks if not used properly.

Upstream product

• 93102-05-7 N-benzyl-N-(methoxymethyl)-N-[(trimethylsilyl)methyl]amine 
• 20026-96-4 ethyl 3-(4-chlorophenyl)propiolate 
• 1229236-32-1 1-Benzyl-4-(4-chloro-phenyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid 
• 1310819-12-5 (3R,4R)-1-benzyl-4-(4-chloro-phenyl)-pyrrolidine-3-carboxylic acid 
• 35086-79-4 cinnamoyl chloride 
• 1615-02-7 3-(4-chlorophenyl)prop-2-enoic acid 
• 862283-67-8 (S)-4-benzyl-3-((3S,4R)-1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carbonyl)oxazolidin-2-one 
• 616-38-6 carbonic acid dimethyl ester 
• 1310819-13-6 (3R,4R)-1-benzyl-4-(4-chloro-phenyl)-pyrrolidine-3-carboxylic acid methyl ester 
• 637-87-6 1-Chloro-4-iodobenzene 

Downstream Products

• 1310819-14-7 (3S,4R)-1-benzyl-4-(4-chloro-phenyl)-pyrrolidine-3-carboxylic acid amide 
• 1310819-15-8 [(3S,4R)-1-benzyl-4-(4-chloro-phenyl)-pyrrolidin-3-yl]-carbamic acid methyl ester 
• 1310819-51-2 [(3S,4R)-1-benzyl-4-(4-chloro-phenyl)-pyrrolidin-3-yl]-methyl-carbamic acid tert-butyl ester 
• 1310819-16-9 [(3S,4R)-1-benzyl-4-(4-chloro-phenyl)-pyrrolidin-3-yl]-methyl-amine 
• 862283-71-4 (3S,4R)-methyl 4-(4-chlorophenyl)pyrrolidine-3-carboxylate hydrochloride 

Relevant articles and documents

Structure-based design of potent and selective leishmania N -myristoyltransferase inhibitors

Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leishmaniasis, obtained from a high-throughput screen, were resynthesized to validate activity. Crystal structures bound to Leishmania major NMT were obtained,

PYRROLIDINE DERIVATIVES

The present invention relates to compounds of formula (I) or to a pharmaceutically active salt thereof. It has been found that the present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's